During the EVEDA (Engineering Validation and Engineering Design Activities) phase of the IFMIF (International Fusion Materials Irradiation Facility) project, a 125 mA/9 MeV prototype accelerator (LIPAc) has to be built, tested an operated in Rokkasho-Mura (Japan). Involved in this project for several years, CEA/Saclay designed the injector of this accelerator which is composed by an ECR ion source, delivering a 140 mA deuteron beam at 100 keV, and a low energy beam transport (LEBT) line to match the beam for the injection into the RFQ. In this paper, the components of the LIPAc injector are described. The commissioning of the ion source and LEBT with beam started in November 2014. The different phases of the commissioning are explained and some noticeable experimental results obtained with a D + beam at 100 keV are presented.
The Linear IFMIF (International Fusion Materials Irradiation Facility) Prototype Accelerator (LIPAc) is aiming at demonstrating the low energy section of a 40 MeV/125 mA IFMIF deuteron accelerator up to 9 MeV with a full beam current in cw operation. For such a high-power beam, the LIPAc injector is required to produce a 100 keV D+ beam with 140 mA and match it for injection into the Radio Frequency Quadrupole (RFQ) accelerator. The injector is designed by CEA-Saclay based on the high intensity light ion source (SILHI). In 2019, the commissioning of the RFQ to demonstrate the D+ beam acceleration at a low duty cycle (0.1%) was conducted. A nominal beam current of 125 mA D+ beam was accelerated up to 5 MeV through the RFQ successfully. The LIPAc injector fully satisfied the requirements for RFQ beam commissioning at the pulse mode.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.